Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Wenstrup Richard

2. Date of Event Requiring Statement (MM/DD/YYYY) 7/1/2015

3. Issuer Name and Ticker or Trading Symbol

MYRIAD GENETICS INC [MYGN]

(Last) (First) (Middle)

320 WAKARA WAY

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
Chief Medical Officer /

(Street)

SALT LAKE CITY, UT 84108

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Incentive Stock Option (right to buy)	9/15/2014	9/15/2020	Common Stock	808	$16.53	D
Incentive Stock Option (right to buy)	2/23/2015	2/23/2021	Common Stock	3750	$18.0	D
Incentive Stock Option (right to buy)	⁽¹⁾	9/13/2021	Common Stock	1669	$19.47	D
Incentive Stock Option (right to buy)	⁽²⁾	3/7/2022	Common Stock	1500	$23.98	D
Incentive Stock Option (right to buy)	⁽³⁾	9/17/2021	Common Stock	3775	$26.49	D
Incentive Stock Option (right to buy)	⁽⁴⁾	9/12/2022	Common Stock	2365	$27.07	D
Non-Qualified Stock Option (right to buy)	9/15/2014	9/15/2020	Common Stock	14192	$16.53	D
Non-Qualified Stock Option (right to buy)	2/23/2015	2/23/2021	Common Stock	10250	$18.0	D
Non-Qualified Stock Option (right to buy)	⁽¹⁾	9/13/2021	Common Stock	20331	$19.47	D
Non-Qualified Stock Option (right to buy)	⁽²⁾	3/7/2022	Common Stock	4500	$23.98	D
Non-Qualified Stock Option (right to buy)	⁽³⁾	9/17/2021	Common Stock	23725	$26.49	D
Non-Qualified Stock Option (right to buy)	⁽⁴⁾	9/12/2022	Common Stock	22635	$27.07	D

Explanation of Responses:
( 1)	Vests 25% a year over four years - initial vesting 9/13/12, final vesting 9/13/15
( 2)	Vests 25% a year over four years - initial vesting 3/7/13, final vesting 3/7/16
( 3)	Vests 25% a year over four years - initial vesting 9/17/14, final vesting 9/17/17
( 4)	Vests 25% a year over four years - initial vesting 9/12/13, final vesting 9/12/16

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Wenstrup Richard 320 WAKARA WAY SALT LAKE CITY, UT 84108			Chief Medical Officer

Signatures
By: Richard M. Marsh For: Richard J. Wenstrup		7/2/2015
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.